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de Recherche en Infectiologie, INSERM U1111, Lyon, FranceABSTRACT The major histocompatibility complex (MHC) class II protein can bind peptides of different lengths in the region
outside the peptide-binding groove. Peptide-flanking residues (PFRs) contribute to the binding affinity of the peptide for MHC
and change the immunogenicity of the peptide/MHC complex with regard to T cell receptor (TCR). The mechanisms underlying
these phenomena are currently unknown. The molecular flexibility of the peptide/MHC complex may be an important determi-
nant of the structures recognized by certain T cells. We used single-molecule x-ray analysis (diffracted x-ray tracking (DXT)) and
fluorescence anisotropy to investigate these mechanisms. DXT enabled us to monitor the real-time Brownian motion of the
peptide/MHC complex and revealed that peptides without PFRs undergo larger rotational motions than peptides with PFRs.
Fluorescence anisotropy further revealed that peptides without PFRs exhibit slightly larger motions on the nanosecond time-
scale. These results demonstrate that peptides without PFRs undergo dynamic motions in the groove of MHC and consequently
are able to assume diverse structures that can be recognized by T cells.INTRODUCTIONT cell receptor (TCR) recognizes peptides that are derived
from antigenic proteins and are bound to host major histo-
compatibility complex (MHC) molecules present on the
surface of antigen-presenting cells (1). As a result of VDJ
recombination, a large number of TCRs can be generated
within the body. However, the possible number of peptide/
MHC complexes is enormous and far larger than the number
of potential recombined TCRs; therefore, a given TCR must
be able to cross-react with thousands of antigens (2,3). The
cross-reactivity of TCR is well documented, and crystal
structures of free TCR in complex with MHC clearly reveal
repositioning of the loops of the complementarity-deter-
mining region (4–8). On the other hand, class I-bound pep-
tides in the MHC groove deform upon TCR binding; thus,
longer peptides can bind class I MHC and still activate
T cells, which flatten the bulged peptide loops upon binding
(9,10). Furthermore, class I MHC exhibits a conformational
variation in the a-helix that is dependent on bound peptide
(11).
No such studies have been performed for class II MHC
(MHC II), however, because peptides are believed to be a
part of the MHC folding complex, and the Debye-Waller
factor (B factor) indicates that peptides in the crystal adopt
rigid conformations (12). However, the notion that MHC II
binds peptides primarily via hydrogen bonds raises the pos-Submitted May 22, 2014, and accepted for publication December 2, 2014.
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0006-3495/15/01/0350/10 $2.00sibility of flexible motion of peptides in the binding groove
of MHC II (12–18). Furthermore, it has become clear that
single peptides in complex with an MHC II molecule adopt
multiple conformations (a minimum of two, called the type
A and type B complexes) (19,20). Type A complexes ac-
quire peptides in late endosomes through DM catalysis,
whereas type B complexes acquire peptides in recycling en-
dosomes or at the cell surface (19–21). DM translocates the
peptide into the binding groove by an as-yet-unknown
mechanism. Thus, we can assume that type A complexes
adopt a rigid conformation, whereas type B complexes
adopt a flexible conformation; however, beyond this rough
assessment (22), the structural differences between type A
and type B MHC complexes remain unknown.
In addition to DM catalysis in the late endosome, the
length of the peptide affects the affinity of peptides for
MHC II: specifically, the addition of a few residues to the
region outside the groove is necessary for efficient peptide
binding (23). Longer peptides that contain peptide-flanking
residues (PFRs) have a greater tendency to form type A
MHC complexes (22). PFRs also alter the antigenicity of
the peptide in a way that corresponds to the ratio of the
proportions of the type A and type B complexes (24,25).
Hen egg lysozyme peptides (pHELs) of different lengths
are a well-studied system for investigating the antigenicity
of the type A and type B conformations (19,20), and we em-
ployed that system in this study. The HEL48-61 peptide
contains four N-terminal PFRs and primarily forms a type
A MHC II complex. By contrast, the HEL52-61 peptidehttp://dx.doi.org/10.1016/j.bpj.2014.12.004
Motion of MHC Class II/Peptide Complex 351lacks the N-terminal PFRs and primarily forms a type B
MHC II complex. These differences were exploited in this
study.
The structural isotypes of MHC II may arise from differ-
ences in the flexibilities of the peptide complexes. To deter-
mine the differences between the structural isotypes, we
used the diffracted x-ray tracking (DXT) method (26,27),
which utilizes gold nanocrystals (average size 20–25 nm)
that are covalently attached to the protein of interest. Irradi-
ation of the labeled protein with white x-rays results in sin-
gle diffraction spots that can be monitored in real time, and
the trajectories of the diffraction spots can be translated into
movements in real space. Next, we analyzed an I-Ak/peptide
complex by using fluorescence anisotropy, which revealed
increased motion of the peptides on the nanosecond time-
scale. Comparative molecular-dynamics (MD) simulations
exhibited large conformational fluctuations, particularly in
the additional N-terminal amino acids that lie outside the
groove, and a rather rigid structure throughout the rest of
the peptide.MATERIALS AND METHODS
Peptides
Peptides were purchased from Peptide 2.0 (Chantilly, VA). Peptide
sequences are; pHEL48-61 (DGSTDYGILQINSR); pHEL48-61(52A)
(DGSTAYGILQINSR); pHEL52-61 (DYGILQINSR); pHEL48-61(56C)
(DGSTDYGICQINSR); pHEL48-61 (52A, 56C) (DGSTAYGICQINSR);
pHEL52-61(56C) (DYGCQINSR); and FITC-pHEL50-61 (STDGSTDY
GILQINSR).Production and purification of soluble MHC
The ectodomain of MHC with the class II-associated invariant chain pep-
tide (CLIP) covalently bound to the N-terminus of the b chain was gener-
ated as previously described (28). The I-Ak/CLIP construct contained a
thrombin cleavage site in the N-terminus of CLIP. Six-histidine tags were
attached to the C-terminus of both the a and b chains. Constructs were in-
tegrated into pFastBac Dual (Thermo Fisher Scientific, Waltham, MA) and
baculoviruses were generated according to the manufacturer’s protocol.
SFþ cells were infected and cultured with SF-900 II serum-free medium
(Thermo Fisher Scientific) at 18C for 6–7 days. Culture supernatants con-
taining the proteins were concentrated and exchanged with 10 mM sodium
phosphate (pH 5.6) and 300 mMNaCl using a Vivaflow 50 (Sartorius, Goet-
tingen, Germany). After adjustment to pH 7.0, the proteins were isolated
with Co-Sepharose (TALON metal affinity resin; Clontech, Mountain
View, CA) in 20 mM imidazole, 50 mM phosphate buffer (PB, pH 7.0),
and 0.5 M NaCl, and eluted with 150 mM imidazole, 50 mM PB (pH
7.0), and 0.5 M NaCl. Aggregated proteins were removed by gel filtration
chromatography using a Superdex-200 column (GE Healthcare, Pittsburgh,
PA). The peptide was exchanged by digestion of I-Ak/CLIP with thrombin
(Novagen, Madison, WI) in the presence of the desired peptides, followed
by incubation at pH 5.2 overnight at room temperature.Competition assay
Soluble I-Ak/CLIP (20 nM) was bound to 1 mM fluorescein isothiocya-
nate (FITC)-pHEL-50-61 and 0–400 mM of unlabeled competitor
peptide with thrombin. After incubation for 48 h at room temperature,the I-Ak/ FITC-HEL50-61 complex was separated from the free peptide
with a Micro Bio-Spin 30 column (Bio-Rad, Hercules, CA). FITC intensity
was measured by injecting the sample into an LC-20AT high-performance
liquid chromatography (HPLC) unit (Shimadzu, Tokyo, Japan) equipped
with a BioSep-SEC-S 3000 column (300  7.8 mm; Phenomenex, Los An-
geles, CA) connected to an in-line fluorescence detector (RF-10AXL fluo-
rescence detector; Shimadzu, Tokyo, Japan). The strength of each peptide’s
affinity was determined from the concentration of competitor peptide that
yielded the half-maximum of the fluorescence intensity.Production of gold nanocrystals
Gold nanocrystals were produced by epitaxial growth on an NaCl(100) sub-
strate (29). The samples were prepared by thermal vacuum evaporation
(ANELVA L-300EK; Canon Anelva, Kanagawa, Japan) of 99.95% gold
from a tungsten basket in a vacuum of ~2.0  104 Pa. Cleaved
NaCl(100) (10  10 mm) was used as the substrate and maintained at
~475C during the deposition. The distance between the filament and the
substrate was 150 mm. Gold was deposited at a rate of 0.1 nm/min onto
the substrate, and a constant filament temperature of 1486.7 5 4.3 K, as
determined with a radiation thermometer (CHINO; IR-AH, Tokyo, Japan),
was used in the experiments. To detach the gold nanocrystals from the
NaCl(100) substrate, the substrates were dissolved in an-decyl-B-D malto-
side solution (50 mM, pH 7.0). A dynamic light scattering device (DLS-
8000DS; Otsuka Electronics, Osaka, Japan) with a 488 nm argon-ion laser
was used to measure the particle size distribution and the stability of the
gold nanocrystals in aqueous solution.DXT
Complexes of I-Ak/CLIP (1–4 mM) were exchanged to either cysteine-
substituted peptides or unsubstituted peptides by incubation with thrombin
(Novagen, Madison, WI) and a 10-fold molar excess of the desired peptides
for 2 h at room temperature, followed by exchange of the pH to 5.2 over-
night and neutralization. Complexes of I-Ak/peptide were immobilized
onto quartz basal plates via histidine tags. Immobilized I-Ak/peptide com-
plexes were labeled with the gold nanocrystals via an electrical charge in
the thiol groups of cysteine. Labeled complexes on the basal plates were
locked in a PBS-filled chamber and irradiated with white x-rays (SPring-
8, BL40XU; Sayo-gun, Hyogo, Japan) to record Laue diffraction from
the gold nanocrystals. The diffraction spots were monitored with an x-ray
image intensifier (V5445P; Hamamatsu Photonics, Shizuoka, Japan)
and a CCD camera (C4880-82; Hamamatsu Photonics) at 656 
494 pixels. The diffraction images were obtained at a video rate of
36 ms/frame (ms/f) and total exposure time of 3.2 s (90 frames). The effec-
tive size of the detector was 150 mm in diameter with a 100 mm sample-to-
detector distance. Custom software written for IGOR Pro (Wavemetrics,
Lake Oswego, OR) was used to track the diffraction spots’ trajectories
and to analyze those motions statistically. The DXT experiments were
performed with the approval of the Japan Synchrotron Radiation Research
Institute (proposal numbers 2008A1857, 2009A1888, 2010B1153,
2011A1236, 2011B1317, 2012A1396, 2014A1030, and 2014B1246).
We analyzed the absolute angular displacement of the peptide and MHC
in the q and c directions, and constructed histograms by recording the seg-
ments of angular displacement per 720 ms (20 frames). We then fitted the
histograms to a normal Gaussian function and compared the fitting param-
eters of the distributions. To reduce noise in an experimental trajectory from
the DXT data, we averaged the data points within a single trajectory, which
yielded the mean-square angular displacement (MSD) for that trajectory
from the DXT data. The data from the DXT analysis of the MHC-peptide
complex were fit to the MSD. The measured spots represent ~50 trajectories
in all of the MSD curves. The values of the diffusion coefficient (D) and
velocity (v) were determined from the plots of (Dq2) versus the interval
times (30).Biophysical Journal 108(2) 350–359
352 Kozono et al.Fluorescence anisotropy
pHEL48-61(L56C) and pHEL52-61(L56C) were labeled with fluorescein-5
maleimide (Thermo Fisher Scientific, Waltham, MA) after Tris(2-carbox-
yethyl)phosphine (Thermo Fisher Scientific) treatment and isolated by a
peptide column using an HPLC system.
CLIP in complex with I-Ak was exchanged to fluorescein-labeled
pHEL48-61(L56C) or pHEL52-61(L56C). Fluorescein-labeled I-Ak/
pHEL48-61 and I-Ak/pHEL52-61 were isolated by gel filtration chromatog-
raphy using a Superdex-200 (GE Healthcare, Pittsburg, PA) column
equilibrated with 20 mM PB (pH 7.0), 150 mM NaCl, and 0.5 mM
EDTA. Time-resolved measurements were performed with a FluoroCube
5000U time-correlated single-photon counting fluorometer (HORIBA,
Kyoto, Japan) with a 457-nm NanoLED pulsed excitation source. The exci-
tation wave length was 452 nm and the emission wave length was 520 nm.
Experiments were performed at room temperature. The anisotropy decay
was fitted with model function:
gðtÞ ¼ y0 þ B expð-t=41Þ þ B expð-t=42Þ; (1)
where g (t) is anisotropy, B is the transition electric dipole moment angle
constant, t is time, 4 is the rotational correlation time for fluorescein,1
and 42 is the rotational correlation time for peptide.
The data were processed and analyzed using Igor software
(WaveMetrics, Lake Oswego, OR).MD simulation
Initial structures of I-Ak/pHEL50-62, I-Ak/pHEL52-58, I-Ak/pHEL52-61,
I-Ak/pHEL48-61, and I-Ak alone for MD simulations were built based on
the x-ray crystal structure of I-Ak/HEL50-62 (31) using the molecular
modeling software MOE (Chemical Computing Group, Montreal, Canada).
All of the initial structures for the MD simulations were spherically sur-
rounded by ~30,000 TIP3P water molecules (32).
After the energy minimizations, all MD simulations were conducted for
6 ns at 300 K using the Amber 8.0 (33) modified for the MDGRAPE-3 sys-
tem (34,35). The Amber ff03 force field (36) was adopted and the simula-
tion time step was set at 1 fs. The bond lengths involving hydrogen atoms
were constrained to equilibrium lengths using the SHAKE method (37).
The temperature was maintained constant at 300 K using the method of Be-
rendsen et al. (38).
To analyze the correlation rate for protein motion, we calculated a cross-
correlation coefficient for the centers of mass of the residues (39). This
value can vary from 1, which represents a completely anticorrelated mo-
tion, to þ1, which corresponds to a completely correlated motion.
We calculated the binding free energies by the molecular-mechanics
Poisson-Boltzmann/surface area (MM-PB/SA) method (40) using the last
1 ns of the MD trajectories.RESULTS
Peptides without PFRs and in complex with MHC
move significantly within the binding groove of
MHC
The affinities of peptides for I-Ak were measured by compe-
tition assay. The dissociation constants exhibited a 5-fold
difference (1.4 mM for pHEL48-61 and 6.8 mM for
pHEL52-61). Although the affinities of peptides seem rela-
tively low, peptides are believed to be a part of folding com-
plex with an MHC class II protein. Thus, these peptides
should not be released in the neutral pH condition as we
measured the motions in phosphate buffer.Biophysical Journal 108(2) 350–359To determine the active structure recognized by type A
and type B T cells, we analyzed the motion of the peptide
within the binding groove of MHC II using the DXT
method. Fig. 1 A presents the geometry of the DXT experi-
ment. Geometrical correlations between the movements of
the vector in real space and those of the spots on the image
frame are indicated. The diffraction spots from single nano-
crystals were video-recorded at a rate of 36 ms/f and the
trace locations were translated into movements in real
space.
The I-Ak/CLIP complex was expressed in baculovirus,
and the cysteine-containing peptide was loaded after CLIP
was cleaved from the groove. The complex was bound to
a Ni2þ-NTA-coated surface using histidine residues intro-
duced into both the a and b chains of MHC, and then labeled
with gold nanocrystals (Fig. 1 B). The gold nanocrystals
preferentially bound to the solvent-exposed cysteine resi-
dues of the peptide. However, in the absence of a cysteine
in the peptide, the gold nanocrystals preferentially bound
to methionine 160 of the MHC II b chain because no
cysteine residues are exposed in the MHC II molecule
(Fig. 1 B). The motion of gold nanocrystals on the MHC
complex were defined as the polar coordinate of the vector
normal to the x-ray diffraction plane of the nonocrystal.
The polar coordinates in the diffraction plane were con-
verted to the orthogonal axes (c-q coordinates). The quartz
surface was irradiated with primary white x-rays and irradi-
ation was carried out in parallel to the longitudinal axis of
the adsorbed MHC molecule. The orientation of the MHC
molecule was controlled by two six-histidine tags on the
quartz surface. If the dynamic movement of an adsorbed
MHC molecule was equal to that of the labeled nanocrystal,
the x-ray diffraction spots were read as the movement of
the MHC molecule. When the MHC molecule tilted, the
diffraction spot moved radially, as defined by the angle q
(Fig. 1 C). However, when the adsorbed MHC molecule
rotated, the spot also rotated on the image plane, with angle
c. Thus, c represents the rotational angle and q represents
the tilt angle (27).
To quantify these movements, we introduced the diffu-
sion coefficients for both peptides and MHC from the
MSD analysis (Fig. 2, left panel). The diffusion coefficients
for the labeled peptide versus the labeled MHC of I-Ak/
pHEL48-61, I-Ak/pHEL52-61, and I-Ak/pHEL48-61(52A)
were 33.6 mrad2/s vs. 20.1 mrad2/s, 48.1 mrad2/s vs.
32.9 mrad2/s, and 74 mrad2/s vs. 41 mrad2/s, respectively.
This result suggests that the motion of the peptide is
always slightly larger than the MHC itself. The diffusion
constants of both the peptide and MHC are larger with
pHEL52-61 than with pHEL48-61, indicating that the
PFRs affect the motion of the peptide and even the MHC.
The anchorless peptide pHEL48-61(52A) shows greater
motion than pHEL52-61, although I-Ak/pHEL48-61(52A)
has similar specificity in terms of the T cell activation
profile.
AB C
FIGURE 1 Principles of single-molecule mea-
surement using DXT. (A) The relative positions of
the gold nanocrystal-labeled peptide/MHC com-
plex on the basal plate, the radiation beam, and
the image plane are shown. Diffraction spots from
single nanocrystals were video-recorded at a rate
of 36 ms/f and the trace locations were translated
into motion in real space. The large black circle
on the left is the umbra of the beam stop for the
direct x-ray beam. q, tilting motion; c, rotational
motion. (B) Schematic model for the peptide
(with the L56C mutation) and MHC (without muta-
tion) labeled with gold nanocrystals. (C) The q di-
rection of the Laue pattern movement is assigned
to the tilted motion of the peptide/I-Ak complex.
The c direction of the Laue pattern movement is as-
signed to the rotational motion of the peptide/I-Ak
complex. To see this figure in color, go online.
Motion of MHC Class II/Peptide Complex 353To examine the properties of each motion, we utilized a
Gaussian plot of 100 sampled trajectories, which simulta-
neously visualized the motions of individual spots at each
time point. Fig. 2 (right panel) shows an overlay histogram
of the probability density plot for the absolute displacement
of q (tilt angle) at 720 ms. Both I-Ak/pHEL48-61 and I-Ak/
pHEL48-61(52A) exhibited similar peaks in the histograms
for the labeled MHC and the labeled peptide. Conversely,
I-Ak/pHEL52-61 exhibited a larger peak for the labeled
peptide than for the labeled MHC. The histograms of thelabeled MHC for the pHEL48-61- and pHEL52-61-bound
complexes were similar, suggesting that the peptides in
the I-Ak/pHEL52-61 complex moved more dynamically
than in the other complexes. We compared the Gaussian
plots as single peaks representing single motions. However,
pHEL48-61(52A)-bound I-Ak seems to have composite
motion, as the small peak appeared at 100.5 (¼ 3.2) mrad/
720 ms, suggesting that replacement of the anchor residue
of bound peptide caused a more dynamic structural
transition than the PFRs. Subsequently, therefore, weBiophysical Journal 108(2) 350–359
AB
C
FIGURE 2 The peptide-labeled I-Ak/pHEL52-
61 complex exhibited larger motion for the q di-
rection than the MHC-labeled complex. (A–C)
CLIP in complex with I-Ak was exchanged with
pHEL48-61 (A), pHEL52-61 (B), or pHEL48-
61(52A) (C) that contained the L56C mutation
(red) or did not contain the mutation (blue).
The complexes were labeled with gold nanocrys-
tals (peptide labeled and MHC labeled) and
analyzed by DXT. Left panels: MSD curves for
the tilted angle Dq2. Right panels: Gaussian plots
for the tilted angle at 720 ms. To see this figure in
color, go online.
354 Kozono et al.concentrated on studying the role of PFRs and compared
pHEL48-61 and pHEL52-61.
We next analyzed the movements of the rotational angle c
as measured by DXT. Fig. 3 A shows the two-dimensional
probability density plots for the absolute displacement of
q and c for two peptides. Both I-Ak/pHEL52-61 at 360 ms
and I-Ak/pHEL52-61 at 720 ms exhibited larger probability
densities in the c direction than I-Ak/pHEL48-61 at 360 ms
and I-Ak/pHEL48-61 at 720 ms. Fig. 3 B presents the over-
lay histogram of the absolute displacement for the c move-
ments of I-Ak/pHEL52-61 and I-Ak/pHEL48-61 at 720 ms.
I-Ak/pHEL48-61 exhibited a peak at 1.5 mrad, whereas
I-Ak/pHEL52-61 exhibited a peak at 2.2 mrad, reflecting
the degree of peptide movement in the groove. Although
the difference in the peak positions between IAk/pHEL48-Biophysical Journal 108(2) 350–35961 and IAk/pHEL52-61 in Fig. 3 B was subtle, the full width
half maximum for the movement distribution in the peptide
without PFRs (pHEL52-61) was larger. This motion width
observed rotationally was converted to the translational
one. This estimated value was ~1 A˚ which might be the
same size as the width of activating conformations for
certain T cells.
In analysis of the x direction of the Gaussian plots, these
time-dependent peak positon’s curves had saturation values
(Fig. 3 C). This means that detected movements were as-
signed to restricted ones. Additionally, it was indicated that
the movements of the peptide without PFRs (pHEL52-61)
was clearly bigger than that of the peptide with PFRs
(pHEL48-61) (Fig. 3 C). In addition, the peptide without
PFRs exhibited a broader Gaussian distribution, whereas
A B
C
D
E
FIGURE 3 The complex of a peptide without
PFRs, I-Ak/pHEL52-61, demonstrates larger c-
directed Brownian motion in DXT. CLIP in
complex with I-Ak was exchanged to either
pHEL48-61 or pHEL52-61 containing the L56C
mutation. The complexes were labeled with gold
nanocrystals and analyzed by DXT. (A) Two-
dimensional probability density plots of the abso-
lute displacement for the tilted angle q (horizontal)
and absolute displacement for the rotational angle
c (vertical) at 36 ms, 180 ms, 360 ms, and 720 ms.
(B) Histograms of the absolute displacement, indi-
cating the Gaussian distribution for the c move-
ment at 720 ms for I-Ak/pHEL48-61 and I-Ak/
pHEL52-61, were obtained in the same experiment
shown in A. (C) Analysis of the peaks of the
Gaussian plots for the c movement. (D) Analysis
of the width of the Gaussian plots for the c move-
ment. (E) The observed angular velocity as a func-
tion of normalized intensity of the diffraction spot
for I-Ak/pHEL48-61 and I-Ak/pHEL52-61. To see
this figure in color, go online.
Motion of MHC Class II/Peptide Complex 355the peptide containing PFRs (pHEL48-61) exhibited a
Gaussian distribution that narrowed over time (Fig. 3 D).
Because the size of the gold nanocrystal is comparable to
that of MHC proteins, one should consider the effect of the
gold nanocrystal on the protein’s dynamics when using the
DXT method. We estimated the degree of disturbance of
the inherent motion of the target protein from the labeled
gold nanocrystal by plotting the angular velocity of the c
direction versus normalized intensity, which we inferred
to be the size of the gold nanocrystal (41). The size of
gold nanocrystal bound to the target protein was between
20 and 80 nm, and within this range we could not find
much difference in velocity, which suggests that the size
effects of gold nanocrystals are minimal in such measure-
ments (Fig. 3 E). Taken together, these findings indicate
that pHEL52-61 is highly flexible, resulting in variationsin the structure of the peptide/MHC II complex (i.e., the
TCR ligand).A peptide without PFRs in complex with MHC
exhibits faster motion as determined by
fluorescence anisotropy
To investigate the motion of peptides on the nanosecond
timescale, we examined the time decay of anisotropy using
single-photon-counting time-resolved fluorescence anisot-
ropy. Both pHEL48-61 and pHEL52-61 were labeled with
fluorescein at residue 56. In this experiment, we followed
the decay of anisotropy after a rapid pulse. We calculated
the decay rates using an equation with two variables:
the rotation of fluorescein itself and the motion of the
peptide. As shown in Fig. 4, the anisotropy decay inBiophysical Journal 108(2) 350–359
AB
FIGURE 4 The I-Ak/pHEL52-61 complex exhibited larger motion than
the I-Ak/pHEL48-61 complex in bulk solvent. (A) Anisotropies of I-Ak/
pHEL48-61 and IAk/pHEL52-61 complexes and fluorescein alone. Since
the components are peptide motion and fluorescence rotation, the data
were analyzed by secondary fitting using Eq. 1. (B) The differential dy-
namics of the IAk/pHEL52-61 (42 ¼ 0.96 ns) revealed by steady-state
anisotropy can be attributed to increased fluctuations occurring over the
nanosecond timescale compared with I-Ak/pHEL48-61 (42 ¼ 1.51 ns).
To see this figure in color, go online.
356 Kozono et al.fluorescein-labeled I-Ak/pHEL52-61 was slightly faster
(42 ¼ 0.96 ns) than that in fluorescein-labeled I-Ak/
pHEL48-61 (42 ¼ 1.51 ns), indicating that I-Ak/pHEL52-
61 was more flexible than I-Ak/pHEL48-61 on the nano-
second timescale. The tumbling motion of the peptide/
MHC complex should be almost the same between two
complexes because the total mass and overall structures
are the same (42); therefore, we conclude that the difference
is due to the peptide motion within the binding groove.Comparative MD simulations
To confirm that pHEL52-61 undergoes larger motions than
pHEL48-61 in the groove of I-Ak, we conducted compar-
ative MD simulations. The structures of the I-Ak/peptide
complexes used for the MD simulations were built based
on the crystal structure of I-Ak molecules in complex
with pHEL50-62 (31). As shown in Fig. 5 A, the atomic
fluctuation values of residues of pHEL48-61, pHEL52-
61, and pHEL52-58 within the groove of I-Ak tended to
be similar to those of the crystal structure, suggestingBiophysical Journal 108(2) 350–359that these simulations did not contain obvious artifacts,
whereas the N-terminal PFRs of pHEL48-61, located
outside the I-Ak groove, exhibited larger atomic fluctua-
tions. The final simulated structure of I-Ak/pHEL48-61
exhibited larger conformational differences in the N-ter-
minal PFRs and mild displacement of the C-terminal res-
idues, which are stabilized by peptide-MHC interactions
inside the groove. Taken together, these data indicate
that the large fluctuation of the N-terminus of pHEL48-
61 stabilizes the I-Ak complex, whereas without the fluc-
tuation in the PFRs, a shorter peptide may not be able to
maintain a protein complex that is stable enough to have
biological function.
Subsequently, we analyzed the correlation rate for protein
dynamics. The collective motion of I-Ak/pHEL48-61 ex-
hibited a highly positive correlation between the C-terminus
of the peptide and the binding sites in both the I-Aka and
I-Akb chains (Fig. 5 B). However, there was no correlation
between the N-terminus of the peptide and the binding
site of I-Ak. Within I-Ak/pHEL48-61, there were weak and
negative correlation sites between the I-Aka and I-Akb
chains. Conversely, the C-terminus of the peptide correlated
weakly with the binding groove of the I-Aka chain in
the I-Ak/pHEL52-61 complex (Fig. 5 C). Overall, the
pHEL48-61 complex had a tighter conformation than
pHEL52-61, suggesting that the latter peptide engages in a
greater degree of independent motion relative to MHC.
Next, we calculated the binding free energy of I-Ak/
HEL52-58, I-Ak/HEL52-61, and I-Ak/pHEL48-61 using
the MM-PB/SA method (Fig. 5 D). The binding free energy
increased as the size of the peptide increased, and this ten-
dency was dominated by the value of the binding enthalpy.
Conversely, the calculated entropy did not linearly increase
with the size of the peptide. Thus, the large fluctuations of
the PFRs in I-Ak/pHEL48-61 contribute to entropic stabili-
zation of the complex.DISCUSSION
Our results demonstrate that peptides bound in the MHC
groove exhibit distinct motions, based on differences in
the conformations adopted by peptides of varying length
within these complexes. Some T cells may be biased toward
interaction with a peptide that undergoes conformational
fluctuations in the groove of the MHC molecule, likely
due to recognition of a transitional conformation generated
by the rapidly fluctuating peptide. Borbulevych et al. (6)
proposed that the dynamic properties (i.e., the molecular
motions of the peptide and MHC molecule) of HLA-A2
are differentially tuned by the Tax and Tel1p peptides
(8,11,43). This antigen-dependent tuning of peptide/MHC
molecular flexibility may be similar to the phenomenon
we observed in our DXT experiments. In fact, we initiated
this study based on the observation that I-Ak/HEL52-61
can engage with multiple isotypes more easily than
AB C
D
FIGURE 5 Comparative MD simulations con-
firmed that the PFR-peptide MHC complex is
stabilized by a large fluctuation of the peptide
N-terminus that lies outside the binding groove.
(A) Atomic fluctuations from MD simulations for
I-Ak/pHEL48-61, I-Ak/pHEL52-61, and I-Ak/
pHEL52-58, including the B factors from the crys-
tal structure, are shown. (B and C) The correlation
rates of the protein dynamics are presented for
I-Ak/pHEL48-61 (B) and I-Ak/pHEL52-61 (C).
Positive correlation rates are colored red (correla-
tion rate: 0.75–1.0) or pink (correlation rate: 0.5–
0.75). Negative correlation rates are colored blue
(correlation rate: 0.75–1.0) or light blue (correla-
tion rate: 0.5–0.75). Positive correlations are shown
in the lower-right triangle, and negative correla-
tions are shown in the upper-left triangle. The
intensity of the shading is proportional to the
magnitude of the correlation rate. The horizontal
and vertical axes indicate the residue number
(I-Aka chain: 1-182; I-Akb chain: 183-367;
pHEL48-61: 368-381; and pHEL52-61: 368-377).
(D) The binding free energy was calculated using
the MM-PB/SA method. Blue bars indicate the
binding free energy, red bars indicate the enthalpy,
and yellow bars indicate the entropy. To see this
figure in color, go online.
Motion of MHC Class II/Peptide Complex 357I-Ak/pHEL48-61 because the former peptide activates both
type A and type B T cells to comparable extents, whereas
the latter mainly activates type A T cells (19).
It is worth noting that both DXT and anisotropy showed a
similar tendency in terms of the difference between the pep-
tides, even though the timescales were different. The nano-
second timescale of anisotropy may represent the real
motion of the peptide itself, and the slowmillisecond motion
detected by DXT may represent the coherent motion of the
peptide with the MHC a-helix, which is slower than the pep-
tide itself. This may impact TCR recognition, since the on-
rates of TCR for MHC/peptides are usually very slow (44).
We found that in addition to creating diversity in the TCR
ligand, PFRs played an essential role in the MHC II com-
plex. Because most bound peptides are longer than thegroove, the additional increase in the stability of the pep-
tide/MHC II complex may be a general feature of MHC
II-binding peptides (22). Here, we demonstrate the rationale
for this increased stability: N-terminal PFRs undergo
massive structural fluctuations, which increase the entropy.
In normal protein interactions, the changes in enthalpy
and entropy are compensated for, resulting in a marginal
gain in free energy (45). In the case of MHC II, it is logical
for PFR regions to be free to move so that they can provide
strong stability to the complexes.CONCLUSIONS
This study, in which we measured tiny motions related to
immune functions, may be the first successful effort of itsBiophysical Journal 108(2) 350–359
358 Kozono et al.kind. Previous studies examined the peptide/MHC-TCR
interaction using structural data obtained by x-ray crystal-
lography (4). Although those studies provided new insights
that furthered our understanding of antigen recognition by
T cells, their results were obtained from the most com-
pressed and stable forms of the molecules involved in the
interactions. However, proteins in solution are flexible
and undergo their own unique movements, determined by
intra- and intermolecular interactions. Thus, the extra flexi-
bility of the peptide/MHC complex could play a critical role
in the interaction with TCR.
DXT was developed with the goal of acquiring structural
information about the internal MD of individual molecules
(30). Currently, single-molecule fluorescence resonance en-
ergy transfer (FRET) (46) is used to measure nanometer-
scale distances and changes in distances or intermolecular
orientations between the two fluorophores, both in vitro
and in vivo. However, it is difficult to measure intramolecu-
lar structural changes of single protein molecules using
single-molecule FRET due to the instability of the signal in-
tensity and the lack of monitoring precision under physio-
logical conditions (47). The DXT method has been used
to observe individual DNA molecules (26), denatured pro-
teins (48), and functional membrane proteins (49) such as
KcsA (27), as well as for quantitative single-molecule anal-
ysis of antigen-antibody interactions (50), monitoring of
super-weak forces (on the order of piconewtons) (26), and
studies of ATP-dependent group II chaperonin (51).
The idea that molecular motion plays an important role in
protein-protein interactions is an emerging concept in
biology. Here, we used peptide-MHC interactions to demon-
strate, to our knowledge, a novel protein-protein interaction;
however, it is possible that a wide variety of biological sys-
tems may also depend on such interactions. Using DXT in
combination with biological, biochemical, and structural
analyses in a wide variety of systems should provide infor-
mation regarding the dynamic roles of molecular motion in
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